Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Quantification of R-(+)-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-methyl-3- benzazepine in brain and blood by use of reversed-phase high-performance liquid chromatography with electrochemical detection.

× No keyword cloud information.

11 in total

1. Effect of chronic D-1 and/or D-2 dopamine antagonist treatment on SKF 38393-induced non-stereotyped grooming.

Authors: S A Parashos; C Marin; P Barone; V Kapitzoglou-Logothetis; T N Chase
Journal: Psychopharmacology (Berl) Date: 1990 Impact factor: 4.530

2. Using the self-administration of apomorphine and cocaine to measure the pharmacodynamic potencies and pharmacokinetics of competitive dopamine receptor antagonists.

Authors: Andrew B Norman; Michael R Tabet; Mantana K Norman; Vladimir L Tsibulsky
Journal: J Neurosci Methods Date: 2010-10-23 Impact factor: 2.390

3. The affinity of D2-like dopamine receptor antagonists determines the time to maximal effect on cocaine self-administration.

Authors: Andrew B Norman; Michael R Tabet; Mantana K Norman; Brittney K Fey; Vladimir L Tsibulsky; Ronald W Millard
Journal: J Pharmacol Exp Ther Date: 2011-05-23 Impact factor: 4.030

4. Differential tolerance to cataleptic effects of SCH 23390 and haloperidol after repeated administration.

Authors: J Lappalainen; J Hietala; E Syvälahti
Journal: Psychopharmacology (Berl) Date: 1989 Impact factor: 4.530

5. Hypothyroidism attenuates SCH 23390-mediated depression of breathing and decreases D1 receptor expression in carotid bodies, PVN and striatum of hamsters.

Authors: Evelyn H Schlenker; Harold D Schultz
Journal: Brain Res Date: 2011-05-23 Impact factor: 3.252

Quantification of R-(+)-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-methyl-3- benzazepine in brain and blood by use of reversed-phase high-performance liquid chromatography with electrochemical detection.

1. Effect of chronic D-1 and/or D-2 dopamine antagonist treatment on SKF 38393-induced non-stereotyped grooming.

2. Using the self-administration of apomorphine and cocaine to measure the pharmacodynamic potencies and pharmacokinetics of competitive dopamine receptor antagonists.

3. The affinity of D2-like dopamine receptor antagonists determines the time to maximal effect on cocaine self-administration.

4. Differential tolerance to cataleptic effects of SCH 23390 and haloperidol after repeated administration.

5. Hypothyroidism attenuates SCH 23390-mediated depression of breathing and decreases D1 receptor expression in carotid bodies, PVN and striatum of hamsters.

6. Effects of systemic or nucleus accumbens-directed dopamine D1 receptor antagonism on sucrose seeking in rats.

7. Haloperidol- and SCH23390-induced dopaminergic supersensitivities are not additive in the rat.

8. In hamsters the D1 receptor antagonist SCH23390 depresses ventilation during hypoxia.

9. Quantification of SCH 39166, a novel selective D1 dopamine receptor antagonist, in rat brain and blood.

10. PV plasticity sustained through D1/5 dopamine signaling required for long-term memory consolidation.